THE PHARMACOKINETICS OF METAL- BASED ENGINEERED NANOMATERIALS, FOCUSING ON THE BLOOD-BRAIN BARRIER

作者: Mo Dan

DOI:

关键词: Distribution (pharmacology)ParenchymaCentral nervous systemDrug deliveryIron oxide nanoparticlesBiomedical engineeringHyperthermiaMaterials scienceBlood–brain barrierPharmacokinetics

摘要: OF DISSERTATION THE PHARMACOKINETICS METAL-BASED ENGINEERED NANOMATERIALS, FOCUSING ON BLOOD-BRAIN BARRIER Metal-based engineered nanomaterials (ENMs) have potential to revolutionize diagnosis, drug delivery and manufactured products, leading greater human ENM exposure. It is crucial understand pharmacokinetics their association with biological barriers such as the blood-brain barrier (BBB). Physicochemical parameters size surface modification of ENMs play an important role in fate, including brain association. Multifunctional showed advantages across highly regulated BBB. There are limited reports on distribution among blood vasculature, BBB, parenchyma. In this study, ceria was used study effect its pharmacokinetics. Four sizes were studied. Five nm a longer half-life higher compared other 15 30 had cell than 5 or 55 ceria. Because long circulation high sizes, between BBB parenchyma The situ perfusion technique (99%) luminal rather For biomedical applications central nervous system (CNS), it vital develop stable biocompatible enhance uptake by taking advantage unique properties. Cross-linked nanoassemblies entrapping iron oxide nanoparticles (CNA-IONPs) controlled particle conditions less toxicity comparison Citrate-IONPs. CNA-IONPs considerably enhanced MRI T2 relaxivities generated heat at mild hyperthermic temperatures (40 ~ 42°C) presence alternating magnetic field (AMF). Numerous researchers whole body hyperthermia can increase permeability for therapeutic application. Compared conventional hyperthermia, AMF-induced increased shorter duration lower temperature, providing IONP flux reduced toxicity. Overall, optimized physicochemical properties into desirable pharmacokinetics, which provide great diagnosis therapy CNS.

参考文章(293)
Vladimir P. Torchilin, Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example Drug Delivery. ,vol. 197, pp. 3- 53 ,(2010) , 10.1007/978-3-642-00477-3_1
Jacek Bernacki, Andrzej Małecki, Katarzyna Nierwińska, Aleksandra Dobrowolska, Physiology and pharmacological role of the blood-brain barrier. Pharmacological Reports. ,vol. 60, pp. 600- 622 ,(2008)
Pilar Calvo, Bruno Gouritin, Hélène Chacun, Didier Desmaële, Jean D'Angelo, Jean‐Pierre Noel, Dominique Georgin, Elias Fattal, Jean P. Andreux, Patrick Couvreur, Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery. Pharmaceutical Research. ,vol. 18, pp. 1157- 1166 ,(2001) , 10.1023/A:1010931127745
Young‐Sook Kang, William M. Pardridge, Brain delivery of biotin bound to a conjugate of neutral avidin and cationized human albumin. Pharmaceutical Research. ,vol. 11, pp. 1257- 1264 ,(1994) , 10.1023/A:1018982125649
T. Masui, H. Hirai, N. Imanaka, G. Adachi, T. Sakata, H. Mori, Synthesis of cerium oxide nanoparticles by hydrothermal crystallization with citric acid Journal of Materials Science Letters. ,vol. 21, pp. 489- 491 ,(2002) , 10.1023/A:1015342925372
Istvan A Krizbai, Imola Wilhelm, Csilla Fazakas, In vitro models of the blood-brain barrier. Acta Neurobiologiae Experimentalis. ,vol. 71, pp. 113- 128 ,(2011)
Minoru NAKAGAWA, Kengo MATSUMOTO, Hisato HIGASHI, Tomohisa FURUTA, Takashi OHMOTO, Acute effects of interstitial hyperthermia on normal monkey brain--magnetic resonance imaging appearance and effects on blood-brain barrier. Neurologia Medico-chirurgica. ,vol. 34, pp. 668- 675 ,(1994) , 10.2176/NMC.34.668
Akira Ito, Masashige Shinkai, Hiroyuki Honda, Kazuhiro Yoshikawa, Shinsuke Saga, Toshihiko Wakabayashi, Jun Yoshida, Takeshi Kobayashi, Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles. Cancer Immunology, Immunotherapy. ,vol. 52, pp. 80- 88 ,(2003) , 10.1007/S00262-002-0335-X